This study provides further evidence of the extent to which omicron is able to overcome resistance to infection or vaccination.
London: Researchers at Imperial College London have found no evidence that Kovid’s new variant, the Omicron, is less intense than the Delta variant. According to the report, Omicron was able to overcome the immunity gained from a previous infection or from two vaccine doses, and was 5.4 times more likely to re-infect Delta.
“Based on the ratio of omega-positive patients with symptoms to those hospitalized after infection, there is no evidence that omega-3s have a lower severity than delta,” said those behind the study. She added that the number of people admitted to the hospital was limited.
The study, which has been published in the UK between November 29 and December 11, uses data from all cases where the disease has been confirmed. The research includes people who have been diagnosed with an omicron infection due to a deficiency of the S gene (SGTF) and those who have been confirmed to have an omiciron infection.
A total of 196,463 people without S-gene deficiency, most likely to be affected by another variant, and 11,329 cases were included in the analysis. In addition, 122,063 delta and 1,846 omicron cases were included in the genetic sample analysis. Every two days until December 11, the researchers said, the proportion of omicron doubled in total Kovid cases.
“This study provides further evidence of the extent to which omicron is able to overcome immunity to infection or vaccination. This means that Omicron poses a great threat to public health, “said Neil Ferguson, a professor at Imperial College London.
The researchers also found that people who took two or more weeks after receiving the two-dose vaccine, and those who took the booster dose of the AstraZeneca and Pfizer vaccines, had a significantly higher risk of developing symptomatic omega-3 infections compared to Delta. “The two-dose vaccine provides only zero to 20 percent immunity against the symptomatic omicron. It accounts for 55 to 80 percent of those who receive a booster dose, ”the researchers said.
Also Read: Four more Omicon in the state; Total number of patients15
.